RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells by Pascale Hubert, Patrick Roncarati, Charlotte Pilard, Marie Ancion, Celia Reynders, Thomas Lerho, Diane Bruyere, Alizee Lebeau, Marie-Julie Nokin, Elodie Hendrick, Olivier Peulen, Philippe Delvenne, Michael Herfs, Margaux Luyckx, Michael Renard, Florian Poulain, Rebekah Crake, Raphael Peiffer

Get full text